Urgent

Struvite (infection) stones and staghorn calculi

struvite · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Magnesium-ammonium-phosphate stones formed in persistently alkaline urine from urease-producing organisms (Proteus, Klebsiella). They grow rapidly into staghorn calculi, harbour chronic infection and require complete surgical clearance plus infection control.

Red flags

  • Fever/sepsis with obstruction (pyonephrosis) — emergency decompression
  • Rapidly enlarging staghorn calculus
  • Deteriorating renal function or bilateral disease
  • Recurrent urosepsis despite therapy
  • Non-functioning infected kidney

Assessment

Differential diagnosis

  • Staghorn struvite calculus
  • Cystine staghorn stone
  • Uric acid stone
  • Calcium phosphate stone
  • Matrix stone
  • Infected non-struvite stone

Investigations

  • Non-contrast CT KUB (stone burden/branching)
  • Urinalysis (alkaline pH, pyuria) and urine culture
  • Stone analysis
  • U&E and split renal function (DMSA/MAG3) if nephrectomy considered
  • FBC/CRP for infection severity
  • Serum calcium/urate to exclude metabolic contributors

Management

  • Confirm struvite/infected staghorn stone on imaging and culture urease-producing organisms
  • Assess for sepsis and obstruction — treat infected obstruction as an emergency with decompression (stent/nephrostomy) and antibiotics
  • Plan definitive complete stone removal — residual fragments perpetuate infection and recurrence
  • Percutaneous nephrolithotomy (PCNL) is first-line for staghorn calculi, with adjunctive flexible ureteroscopy/ESWL as needed
  • Culture-directed perioperative antibiotics to minimise urosepsis risk
  • Aim for a stone-free kidney; re-image to confirm clearance
  • Treat underlying contributors (obstruction, foreign body/catheter, neurogenic bladder)
  • Consider urease inhibitor (acetohydroxamic acid) only if surgery impossible and infection persists
  • Provide long-term antibiotic suppression where recurrent infection persists and surveillance imaging
  • Assess and preserve renal function; consider nephrectomy for a non-functioning infected kidney
  • Give general stone prevention advice and metabolic screen for coexisting stones
  • Arrange regular urological follow-up with imaging and cultures

Drugs & doses

Culture-directed IV antibiotics for urosepsis (e.g. gentamicin 5-7 mg/kg IV daily + amoxicillin, per local policy)
Co-amoxiclav 625 mg PO three times daily (culture-directed oral option)
Acetohydroxamic acid 250 mg PO three times daily (urease inhibitor; only if surgery not feasible, monitor for toxicity)
Low-dose suppressive antibiotic (e.g. trimethoprim 100 mg PO nightly) per sensitivities

Disposition

Urology admission for definitive stone clearance; emergency decompression for pyonephrosis. Infectious/nephrology input for complex cases and long-term surveillance.

Complications & pitfalls

  • Pyonephrosis and urosepsis
  • Progressive CKD and loss of the kidney
  • Xanthogranulomatous pyelonephritis
  • Recurrence from residual fragments
  • Rarely, squamous cell carcinoma in chronically infected stones

Exam pearls

  • Struvite stones require complete removal — leaving fragments guarantees recurrence
  • Think urease-producers (Proteus) with persistently alkaline urine
  • Infected obstruction is a surgical emergency, not a prescription for antibiotics alone
  • PCNL is the definitive treatment for staghorn calculi
  • Acetohydroxamic acid is toxic and reserved for inoperable cases

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.